Much of the news has been focused on the novel coronavirus and the rush to develop vaccines and treatments for the disease it causes (called COVID-19). But what is happening with all the other companies not directly involved in COVID-19 research? And how is COVID-19 affecting their clinical trials and drug supplies?

To answer these questions, BioSpace looked at COVID-19s impact on each of the Hotbeds.

Biotech Bay, the bustling biotech industry around San Francisco in California, is home to lots of biopharma companies, many of whom are trying to keep business as close to usual while adapting to these unique times.

Check out the table below for the impacts that Biotech Bay companies are experiencing due to COVID-19.

(For information about what Biotech Bay companies have joined the fight against COVID-19 and how they are working towards vaccines and treatments, check out this article.)

The information in this table was up to date as of May 18, 2020.

4D Molecular Therapeutics

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Allakos, Inc.

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Ambys Medicines

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Apollomics, Inc.

Disease Focus:

Clinical Trial Impacts of COVID-19:

Arcus Biosciences

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Assembly Biosciences

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

BioMarin Pharmaceutical Inc.

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

BridgeBio

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

DNA Script

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Eurofins DiscoverX

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Exelixis, Inc.

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

FibroGen

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Global Blood Therapeutics

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Horizon Therapeutics

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Intabio

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Iovance Biotherapeutics

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

JOINN Biologics

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

Maze Therapeutics

Disease Focus:

Clinical Trial Impacts of COVID-19:

Drug Supply Impacts of COVID-19:

MyoKardia

Disease Focus:

Clinical Trial Impacts of COVID-19:

More:
How COVID-19 is Affecting Clinical Trials and Drug Supplies from Biotech Bay Companies - BioSpace

Comments are closed.